The Usefulness of the TAPSE/sPAP Ratio for Predicting Survival in Medically Treated Chronic Thromboembolic Pulmonary Hypertension

CONCLUSION: Medically treated CTEPH patients with a TAPSE/sPAP ratio ≤0.20 had lower survival rates. TAPSE/sPAP ratio≤0.20 combined with NYHA-FC III-IV was the independent predictor of poor prognosis.PMID:37861261 | DOI:10.5543/tkda.2023.78074

Source: Turk Kardiyoloji Dernegi arsivi - October 20, 2023 Category: Cardiology Authors: Ay şe Çolak Zeynep Kumral Mehmet K ış Bihter Şentürk Dilek Sezgin G ökçen Ömeroğlu Şimşek Can Sevin ç Bahri Akdeniz Source Type: research